Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for CV Sciences (CVSI) over the last 13 years, with Q3 2025 value amounting to $1.9 million.

  • CV Sciences' Non-Current Assets rose 1552.04% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 1966.31%. This contributed to the annual value of $1.7 million for FY2024, which is 3343.9% up from last year.
  • According to the latest figures from Q3 2025, CV Sciences' Non-Current Assets is $1.9 million, which was up 1552.04% from $2.0 million recorded in Q2 2025.
  • CV Sciences' 5-year Non-Current Assets high stood at $13.2 million for Q1 2021, and its period low was $1.1 million during Q1 2024.
  • Over the past 5 years, CV Sciences' median Non-Current Assets value was $1.9 million (recorded in 2025), while the average stood at $3.6 million.
  • Its Non-Current Assets has fluctuated over the past 5 years, first crashed by 7560.04% in 2022, then surged by 6183.32% in 2024.
  • Over the past 5 years, CV Sciences' Non-Current Assets (Quarter) stood at $3.9 million in 2021, then crashed by 58.61% to $1.6 million in 2022, then dropped by 21.42% to $1.3 million in 2023, then soared by 33.44% to $1.7 million in 2024, then rose by 12.71% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $2.0 million for Q2 2025, and $1.8 million during Q1 2025.